Overview

A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets

Status:
Completed
Trial end date:
2017-10-16
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess disintegration of the new Aspirin disintegrating tablets
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Aspirin
Ibuprofen